Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
EGF/EGFR Signaling Pathway WP437	11/162	0.002582846263208178	1.0	0	0	2.716049382716049	16.184566947825523	NDUFA13;IQSEC1;TNK2;EIF4EBP1;E2F1;MYBL2;ARHGEF1;SH3GL2;EPN1;DNM1;BCAR1
MAPK Signaling Pathway WP382	14/246	0.0037322130572470967	0.8808022815103148	0	0	2.2764227642276422	12.726919466121773	HSPB1;TRAF2;CACNA2D4;ARRB2;CACNA1F;MAPK8IP3;MAPK12;CACNA1G;FGF17;PPP5C;TAOK2;MAP3K6;FGF12;MAP3K5
GPR40 Pathway WP3958	3/15	0.005648024777015824	0.8886225649171563	0	0	8.0	41.41159513548328	ITPR3;PLCD3;PKD1
Photodynamic therapy-induced AP-1 survival signaling. WP3611	5/50	0.008040893507605765	0.9488254338974803	0	0	4.0	19.292860276717064	CDKN2A;BAX;TRAF2;MAPK12;MAP3K5
One carbon metabolism and related pathways WP3940	5/52	0.009471810530852916	0.8941389141125153	0	0	3.8461538461538463	17.920904631222058	GPX1;GPX4;SHMT2;PEMT;DNM1
Nucleotide Metabolism WP404	3/19	0.011170818168534696	0.8787710292580627	0	0	6.31578947368421	28.386002662889787	IMPDH1;POLD1;NME2
TP53 Network WP1742	3/19	0.011170818168534696	0.7532323107926252	0	0	6.31578947368421	28.386002662889787	CDKN2A;BAX;TP73
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959	5/55	0.011932232343427853	0.7040017082622433	0	0	3.6363636363636362	16.103679782632323	CDKN2A;HSF1;E2F1;BAX;TP73
Regulation of Actin Cytoskeleton WP51	9/150	0.013266308662009398	0.695744187607604	0	0	2.4	10.37406633839913	FGF17;CHRM4;RASSF7;ARHGEF1;PIP5K1C;FGF12;GIT1;BCAR1;PAK4
Amyotrophic lateral sclerosis (ALS) WP2447	4/38	0.014554726485956956	0.6869830901371683	0	0	4.2105263157894735	17.80985049987152	TOMM40;GPX1;BAX;MAP3K5
Oxidative phosphorylation WP623	5/60	0.016937312232839237	0.7267646703545564	0	0	3.333333333333333	13.594120887625653	NDUFB7;NDUFA11;NDUFS7;NDUFV1;ATP5F1D
DNA Mismatch Repair WP531	2/9	0.019987498286726836	0.7861749326112556	0	0	8.888888888888888	34.779095880349324	LIG1;POLD1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	14/303	0.020808961068013887	0.7555253557001966	0	0	1.848184818481848	7.156858336981304	LAMA5;LAMA3;VEGFB;THBS4;RAB11B;FGF17;STK11;GNGT2;COL5A1;GNB2;EIF4EBP1;MLST8;GNB3;FGF12
MTHFR deficiency WP4288	3/25	0.02374801151107834	0.8006472452306411	0	0	4.8	17.95323109370892	EHMT2;PEMT;COMT
Mammary gland development pathway - Involution (Stage 4 of 4) WP2815	2/10	0.02457569018526242	0.7733150511629242	0	0	8.0	29.64798022792225	E2F1;BAX
PI3K-Akt Signaling Pathway WP4172	15/340	0.024698879495613224	0.7286169451205902	0	0	1.7647058823529411	6.531171883989317	LAMA5;PKN3;LAMA3;VEGFB;PPP2R3B;THBS4;FGF17;STK11;GNGT2;GNB2;EIF4EBP1;MLST8;GNB3;PKN1;FGF12
ATM Signaling Network in Development and Disease  WP3878	4/45	0.02564991223851159	0.7121622692104393	0	0	3.5555555555555554	13.024764902655056	STK11;PPP5C;HSPB1;MAP3K5
Notch Signaling WP268	4/45	0.02564991223851159	0.6725976986987483	0	0	3.5555555555555554	13.024764902655056	JAG2;NCOR2;CTBP1;DVL1
AMP-activated Protein Kinase (AMPK) Signaling WP1403	5/69	0.029098928808491353	0.72287865250568	0	0	2.898550724637681	10.252330191846333	STK11;EEF2K;EIF4EBP1;EEF2;SLC2A4RG
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	5/72	0.034121963499969904	0.8052783385992898	0	0	2.7777777777777777	9.38281669756106	CAMK2B;LAMA5;INF2;ACTN4;DNM1
Synaptic Vesicle Pathway WP2267	4/51	0.03832523471749994	0.8614052755552367	0	0	3.1372549019607843	10.232617191675	SLC17A7;STX3;CPLX1;DNM1
Translation Factors WP107	4/52	0.040729689807035306	0.8738369813145757	0	0	3.076923076923077	9.848609148264439	EEF2K;CLUH;EIF4EBP1;EEF2
Wnt Signaling Pathway WP363	4/52	0.040729689807035306	0.8358440690835072	0	0	3.076923076923077	9.848609148264439	CTBP1;DVL1;ARRB2;ROR2
Nonalcoholic fatty liver disease WP4396	8/155	0.04127099252559589	0.8116628530033859	0	0	2.064516129032258	6.580842087103301	NDUFA13;NDUFB7;NDUFA11;NDUFS7;BAX;TRAF2;NDUFV1;MAP3K5
Myometrial Relaxation and Contraction Pathways WP289	8/156	0.04259625085646538	0.8042172161700664	0	0	2.051282051282051	6.473823666961932	CAMK2B;GNB2;IGFBP2;GNB3;ITPR3;ARRB2;DGKZ;RAMP1
Cardiac Progenitor Differentiation WP2406	4/53	0.04321791047116662	0.7845712977842555	0	0	3.0188679245283017	9.48377441633977	MESP1;GATA4;ROR2;TBXT
Adipogenesis WP236	7/130	0.0449669377075316	0.7860886888131451	0	0	2.1538461538461537	6.680859827081968	NCOR2;CNTFR;DVL1;HMGA1;E2F1;GATA4;MIF
Alpha 6 Beta 4 signaling pathway WP244	3/33	0.048705626415457094	0.821037702431991	0	0	3.6363636363636362	10.988948085170936	LAMA5;LAMA3;EIF4EBP1
Monoamine GPCRs WP58	3/33	0.048705626415457094	0.792726057520543	0	0	3.6363636363636362	10.988948085170936	HTR6;CHRM4;DRD4
p38 MAPK Signaling Pathway WP400	3/34	0.0524623778440582	0.8254080780798491	0	0	3.5294117647058822	10.403502278005256	HSPB1;TRAF2;MAP3K5
Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291	2/16	0.05940541077305161	0.9044952866090439	0	0	5.0	14.116849831533036	SYTL1;SYTL4
Focal Adhesion WP306	9/198	0.061489677512052095	0.9069727433027684	0	0	1.8181818181818181	5.070701751981373	LAMA5;TNK2;LAMA3;VEGFB;ACTN4;PIP5K1C;THBS4;BCAR1;PAK4
Pathways in clear cell renal cell carcinoma WP4018	5/85	0.0618191895456952	0.8842017413808526	0	0	2.352941176470588	6.5495092994558615	PFKL;SHMT2;MLST8;ALDOA;ENO3
Pyrimidine metabolism WP4022	5/85	0.0618191895456952	0.8581958078108275	0	0	2.352941176470588	6.5495092994558615	POLD1;NME2;POLR2E;NME3;TK1
Photodynamic therapy-induced HIF-1 survival signaling WP3614	3/37	0.06453588403923348	0.8703124933290914	0	0	3.2432432432432434	8.888217950878486	PFKL;IGFBP2;BAX
Mitochondrial LC-Fatty Acid Beta-Oxidation WP368	2/17	0.0662415915707929	0.8685008672615069	0	0	4.705882352941176	12.773867020503221	ECI1;ACADS
miR-509-3p alteration of YAP1/ECM axis WP3967	2/17	0.0662415915707929	0.8450278708490337	0	0	4.705882352941176	12.773867020503221	COL5A1;BCAR1
Wnt Signaling WP428	6/115	0.0687933833120841	0.8544862348237814	0	0	2.0869565217391304	5.58604739782375	CAMK2B;CTBP1;SERPINF1;DVL1;PRICKLE2;ROR2
Pancreatic adenocarcinoma pathway WP4263	5/89	0.07230344457543814	0.8750570728104308	0	0	2.2471910112359548	5.903109007052798	CDKN2A;E2F1;BAX;PAK4;GADD45G
G13 Signaling Pathway WP524	3/39	0.07322950908508677	0.8641082072040239	0	0	3.076923076923077	8.04355941437563	TNK2;ARHGEF1;PKN1
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	2/18	0.07332402120449992	0.8441204392322919	0	0	4.444444444444444	11.612742279715478	EIF4EBP1;MAP3K5
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670	2/18	0.07332402120449992	0.8240223335362848	0	0	4.444444444444444	11.612742279715478	LOXL4;PKD1
Bladder Cancer WP2828	3/40	0.07776165816733924	0.8535698291856773	0	0	2.9999999999999996	7.6623203846665575	CDKN2A;DAPK3;E2F1
Apoptosis Modulation and Signaling WP1772	5/91	0.07788799770256499	0.8355257935366063	0	0	2.1978021978021975	5.609853650799394	PIDD1;ENDOG;CDKN2A;BAX;MAP3K5
Extracellular vesicles in the crosstalk of cardiac cells WP4300	2/19	0.08063617099611983	0.8457838380037458	0	0	4.2105263157894735	10.601296667256518	HSPB1;GATA4
Overview of nanoparticle effects WP3287	2/19	0.08063617099611983	0.8273972328297513	0	0	4.2105263157894735	10.601296667256518	LAMA3;BAX
Cell Cycle WP179	6/120	0.08075142485046569	0.8109504793493576	0	0	2.0	5.032759343656081	MAD2L2;CDKN2C;CDKN2A;E2F1;PKMYT1;GADD45G
Non-small cell lung cancer WP4255	4/66	0.08305732510112497	0.8167303634943955	0	0	2.4242424242424243	6.03205877749113	CDKN2A;E2F1;BAX;GADD45G
G Protein Signaling Pathways WP35	5/93	0.08369783822179734	0.8062322375650683	0	0	2.150537634408602	5.334499203261968	GNGT2;GNB2;GNB3;ARHGEF1;AKAP5
Nanomaterial induced apoptosis WP2507	2/20	0.08816218183787267	0.832250996549518	0	0	4.0	9.714308741076266	ENDOG;BAX
DNA Damage Response WP707	4/68	0.09037481756509516	0.8364100762887239	0	0	2.352941176470588	5.655975569761716	PIDD1;E2F1;BAX;GADD45G
Nicotine Activity on Dopaminergic Neurons WP1602	2/21	0.09588684119947874	0.870357481656807	0	0	3.8095238095238093	8.931758172484527	KCNK3;DRD4
Hedgehog Signaling Pathway WP4249	3/44	0.09705771960273352	0.8643630877828343	0	0	2.727272727272727	6.361225718177528	GRK2;ARRB2;CSNK1G2
Integrated Cancer Pathway WP1971	3/44	0.09705771960273352	0.848356363935004	0	0	2.727272727272727	6.361225718177528	E2F1;BAX;MAP3K5
miRNA Regulation of DNA Damage Response WP1530	4/71	0.10190606046315834	0.8745392825201952	0	0	2.2535211267605635	5.14637490908864	PIDD1;E2F1;BAX;GADD45G
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	7/158	0.10205295161578054	0.8601605921901502	0	0	1.7721518987341771	4.044517536301507	NEUROD1;FEV;MAZ;GNB3;ALDOA;CC2D1A;TP73
Glycolysis and Gluconeogenesis WP534	3/45	0.10215828081331627	0.8459422551558821	0	0	2.6666666666666665	6.0832850553957645	PFKL;ALDOA;ENO3
Fatty Acid Biosynthesis WP357	2/22	0.10379556080326813	0.8446811155024578	0	0	3.6363636363636362	8.237571185428129	ECH1;ECHDC2
Aryl Hydrocarbon Receptor WP2586	3/46	0.10736313441562158	0.8589050753249726	0	0	2.6086956521739126	5.821404549935052	NCOR2;E2F1;AIP
Selenium Metabolism and Selenoproteins WP28	3/46	0.10736313441562158	0.8445899907362231	0	0	2.6086956521739126	5.821404549935052	SELENOO;GPX1;GPX4
Glutathione metabolism WP100	2/23	0.11187435504137663	0.865650747205406	0	0	3.4782608695652173	7.618709103989623	GPX1;GPX4
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	6/132	0.11383527289497382	0.8666169162327039	0	0	1.8181818181818181	3.950914273046745	MINK1;EIF4EBP1;MLST8;MAP3K6;MAPK12;MAP3K5
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612	2/24	0.12010982001247623	0.8998703975537902	0	0	3.333333333333333	7.064495959797489	GSTP1;MAPK12
Senescence and Autophagy in Cancer WP615	5/105	0.12309486929886125	0.9078246610791018	0	0	1.9047619047619047	3.99009509674713	CDKN2A;FKBP8;HMGA1;MLST8;E2F1
Ectoderm Differentiation WP2858	6/138	0.13258979837071028	0.9628059204765423	0	0	1.7391304347826086	3.5139045905290915	NUMA1;CTBP1;SGSM3;ZNF219;RHPN1;ROR2
VEGFA-VEGFR2 Signaling Pathway WP3888	9/236	0.13868562621873506	0.9918123572006508	0	0	1.5254237288135593	3.0135441191131322	BIN1;GIPC1;MLST8;HSPB1;ARRB2;EPN1;MAPK12;BCAR1;MAP3K5
mir-124 predicted interactions with cell cycle and differentiation  WP3595	1/6	0.14094786294456849	0.992946138952781	0	0	6.666666666666666	13.062434822233206	STK11
Apoptosis WP254	4/84	0.15880894471190304	1.0	0	0	1.9047619047619047	3.5048636282938084	CDKN2A;BAX;TRAF2;TP73
Acetylcholine Synthesis WP528	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	PEMT
Arachidonate Epoxygenase / Epoxide Hydrolase WP678	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	GSTP1
Glial Cell Differentiation WP2276	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	CNP
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	VEGFB
MAPK Cascade WP422	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	MAPK12;SIPA1
Mitochondrial complex I assembly model OXPHOS system WP4324	3/56	0.164424419508895	1.0	0	0	2.142857142857143	3.868509150496886	NDUFA13;NDUFB7;NDUFV1
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	4/86	0.1684397588656009	1.0	0	0	1.8604651162790697	3.3138178739793065	CTBP1;SERPINF1;DVL1;ROR2
Calcium Regulation in the Cardiac Cell WP536	6/149	0.17044793665898042	1.0	0	0	1.610738255033557	2.8499200843945487	CAMK2B;CHRM4;GNB2;GNB3;ITPR3;ARRB2
Gastric Cancer Network 2 WP2363	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	CHTF18;LMNB2
Tumor suppressor activity of SMARCB1 WP4204	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	CDKN2A;DPF1
Dual hijack model of Vif in HIV infection WP3300	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	ELOB
Breast cancer pathway WP4262	6/154	0.1889955279135241	1.0	0	0	1.5584415584415583	2.5964133912243836	JAG2;FGF17;DVL1;E2F1;BAX;GADD45G
RIG-I-like Receptor Signaling WP3865	3/60	0.18933665205922548	1.0	0	0	2.0	3.3284572412017854	PIN1;TRAF2;MAPK12
Prader-Willi and Angelman Syndrome WP3998	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	CDKN2C;CDKN2A;E2F1
TNF alpha Signaling Pathway WP231	4/92	0.19848367636943562	1.0	0	0	1.7391304347826086	2.8122581167844345	BAX;CYBA;TRAF2;MAP3K5
Fluoropyrimidine Activity WP1601	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	TK1;SLC29A1
MECP2 and Associated Rett Syndrome WP3584	3/62	0.20213542656566247	1.0	0	0	1.9354838709677418	3.0944852471126474	GAMT;CNP;E2F1
Corticotropin-releasing hormone signaling pathway WP2355	4/93	0.2036425912242253	1.0	0	0	1.7204301075268817	2.737873248162342	GNB2;GNB3;ARRB2;MAP3K5
Methylation Pathways WP704	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	COMT
BDNF-TrkB Signaling WP3676	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	EEF2K;EIF4EBP1
Fatty Acid Beta Oxidation WP143	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	ECI1;ACADS
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	4/94	0.20884064659492504	1.0	0	0	1.7021276595744679	2.665844722244623	CTBP1;SERPINF1;DVL1;ROR2
Insulin Signaling WP481	6/160	0.21221988601068234	1.0	0	0	1.4999999999999998	2.3251985154973505	PFKL;MINK1;EIF4EBP1;MAP3K6;MAPK12;MAP3K5
G1 to S cell cycle control WP45	3/64	0.21512892953081966	1.0	0	0	1.875	2.8809707969055927	CDKN2C;CDKN2A;E2F1
Type III interferon signaling WP2113	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	IFNLR1
Target Of Rapamycin (TOR) Signaling WP1471	2/36	0.22698728149273847	1.0	0	0	2.222222222222222	3.2952473149705526	EIF4EBP1;MLST8
Chemokine signaling pathway WP3929	6/164	0.22822746635921873	1.0	0	0	1.4634146341463412	2.1620670554471664	GRK2;GNGT2;GNB2;GNB3;ARRB2;BCAR1
Folate Metabolism WP176	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	GPX1;GPX4;SHMT2
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	E2F1;SCRIB;RAP1GAP
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	MTA1;E2F1
RAC1/PAK1/p38/MMP2 Pathway WP3303	3/68	0.2416025942539262	1.0	0	0	1.7647058823529411	2.5066960150114252	EIF4EBP1;BAX;MAPK12
Parkin-Ubiquitin Proteasomal System pathway WP2359	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	STUB1;TUBB4B;TUBA4A
Electron Transport Chain (OXPHOS system in mitochondria) WP111	4/103	0.2571271620434609	1.0	0	0	1.553398058252427	2.1098012000212023	NDUFB7;NDUFS7;NDUFV1;ATP5F1D
ATM Signaling Pathway WP2516	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	PIDD1;TP73
Oxidative Damage WP3941	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	TNK2;TRAF2
Cell Differentiation - Index WP2029	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	TLX2
Disorders of Folate Metabolism and Transport WP4259	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	SHMT2
Dopamine metabolism WP2436	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	COMT
Genes targeted by miRNAs in adipocytes WP1992	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	HCN2
Homologous recombination WP186	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	POLD1
Kennedy pathway from Sphingolipids WP3933	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	PEMT
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	ITPR3
Purine metabolism WP4224	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	IMPDH1
Vitamin B12 Disorders WP4271	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CD320
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	ACTN4;CACNA2D4;CACNA1F
DNA Replication WP466	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	CDT1;POLD1
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation WP314	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	HSPB1;LMNB2
Metabolic reprogramming in colon cancer WP4290	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	PFKL;SHMT2
Splicing factor NOVA regulated synaptic proteins WP4148	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	CLSTN1;RAP1GAP
Thermogenesis WP4321	4/108	0.2848542905983054	1.0	0	0	1.4814814814814814	1.8604110970526841	DPF1;MLST8;MAPK12;MAP3K5
Vitamin A and Carotenoid Metabolism WP716	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	RBP7;RBP4
DNA Damage Response (only ATM dependent) WP710	4/110	0.29606967026845615	1.0	0	0	1.4545454545454544	1.77041524338222	CDKN2A;DVL1;BAX;TP73
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	E2F1
Heart Development WP1591	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	VEGFB;GATA4
Vitamin D Receptor Pathway WP2877	6/182	0.304259249085134	1.0	0	0	1.3186813186813187	1.569066129170239	CDC34;CRACR2B;CDKN2C;CDKN2A;NINJ1;MYO9B
Biogenic Amine Synthesis WP550	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	COMT
GPCRs, Class C Metabotropic glutamate, pheromone WP501	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	GRM8
miRNAs involved in DNA damage response WP1545	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	E2F1
Aryl Hydrocarbon Receptor Pathway WP2873	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	AIP;BAX
ESC Pluripotency Pathways WP3931	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	FGF17;DVL1;FGF12;MAPK12
Hedgehog Signaling Pathway WP47	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	GRK2
Signaling Pathways in Glioblastoma WP2261	3/82	0.33702536869684624	1.0	0	0	1.4634146341463412	1.5916054733134235	CDKN2C;CDKN2A;E2F1
Rett syndrome causing genes WP4312	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	NCOR2;XAB2
Canonical and Non-Canonical TGF-B signaling WP3874	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	LOXL4
Leptin Insulin Overlap WP3935	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	DGKZ
NOTCH1 regulation of human endothelial cell calcification WP3413	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	JAG2
Serotonin and anxiety WP3947	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CAMK2B
Synaptic signaling pathways associated with autism spectrum disorder WP4539	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	CAMK2B;EIF4EBP1
Selenium Micronutrient Network WP15	3/86	0.36442414082249097	1.0	0	0	1.3953488372093021	1.4085165595114748	SELENOO;GPX1;GPX4
Estrogen metabolism WP697	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	COMT
Cell Differentiation - Index expanded WP2023	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	TLX2
Mitochondrial Gene Expression WP391	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	POLRMT
Serotonin Receptor 4/6/7 and NR3C Signaling WP734	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	HTR6
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	HSPB1;PKN1
Interferon type I signaling pathways WP585	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	MLST8;EIF4EBP1
Hypertrophy Model WP516	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	EIF4EBP1
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	GATA4
Urea cycle and metabolism of amino groups WP497	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	GAMT
ErbB Signaling Pathway WP673	3/91	0.39839258143942596	1.0	0	0	1.3186813186813187	1.2136053287868656	CAMK2B;EIF4EBP1;PAK4
Pathogenic Escherichia coli infection WP2272	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	TUBB4B;TUBA4A
Glycerophospholipid Biosynthetic Pathway WP2533	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PEMT
Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	BAX
miRNA targets in ECM and membrane receptors WP2911	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	COL5A1
Preimplantation Embryo WP3527	2/58	0.4274492922819714	1.0	0	0	1.379310344827586	1.1723029133595582	HMGA1;TPRX1
Human Complement System WP2806	3/97	0.4384603644337263	1.0	0	0	1.2371134020618557	1.0199825075033913	LAMA5;F12;ARRB2
Blood Clotting Cascade WP272	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	F12
Hippo-Yap signaling pathway WP4537	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	MINK1
Notch Signaling Pathway WP61	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	NCOR2;JAG2
GPCRs, Class B Secretin-like WP334	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	ADGRL1
miRNA regulation of p53 pathway in prostate cancer WP3982	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	BAX
Integrin-mediated Cell Adhesion WP185	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	MAPK12;BCAR1;PAK4
Glycosylation and related congenital defects. WP4521	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	DPM3
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	FBN3
Physiological and Pathological Hypertrophy  of the Heart WP1528	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	GATA4
Signal Transduction of S1P Receptor WP26	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	MAPK12
Endometrial cancer WP4155	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	BAX;GADD45G
Wnt Signaling Pathway and Pluripotency WP399	3/102	0.4710573837797299	1.0	0	0	1.176470588235294	0.8856180687760349	CTBP1;DVL1;PPP2R3B
Pathways Affected in Adenoid Cystic Carcinoma WP3651	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	CTBP1;UHRF1
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	GPX1;DVL1
Canonical  and Non-canonical Notch signaling WP3845	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	JAG2
Follicle Stimulating Hormone (FSH) signaling pathway WP2035	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	EIF4EBP1
Intraflagellar transport proteins binding to dynein WP4532	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	WDR34
Histone Modifications WP2369	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	KMT5C;EHMT2
Nanoparticle-mediated activation of receptor signaling WP2643	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	MAPK12
Cannabinoid receptor signaling WP3869	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MAPK12
Gastric Cancer Network 1 WP2361	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MYBL2
Dopaminergic Neurogenesis WP2855	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	NEUROD1
Inflammatory Response Pathway WP453	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	LAMA5
Matrix Metalloproteinases WP129	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	BSG
Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS WP4304	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	CNP
One Carbon Metabolism WP241	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	SHMT2
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	EIF4EBP1
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	CAMK2B;MAPK12
Ethanol effects on histone modifications WP3996	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	EHMT2
Trans-sulfuration and one carbon metabolism WP2525	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SHMT2
Chromosomal and microsatellite instability in colorectal cancer  WP4216	2/73	0.548068839980631	1.0	0	0	1.095890410958904	0.6590184981053064	BAX;GADD45G
Initiation of transcription and translation elongation at the HIV-1 LTR WP3414	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	NELFA
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	PNCK
Endothelin Pathways WP2197	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	RAMP1
Oxidative Stress WP408	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	GPX1
Resistin as a regulator of inflammation WP4481	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PLCD3
Circadian rhythm related genes WP3594	5/201	0.5670425168236146	1.0	0	0	0.9950248756218906	0.564498499986165	RAI1;MTA1;USP2;CRX;DRD4
Spinal Cord Injury WP2431	3/118	0.5688860293435293	1.0	0	0	1.0169491525423728	0.5736357608562849	RTN4R;E2F1;MIF
Leptin signaling pathway WP2034	2/76	0.5699678510175187	1.0	0	0	1.0526315789473684	0.5917634962819259	EIF4EBP1;BAX
Type 2 papillary renal cell carcinoma WP4241	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	ELOB
Wnt Signaling in Kidney Disease WP4150	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	DVL1
Alzheimers Disease WP2059	2/83	0.6180333278447322	1.0	0	0	0.963855421686747	0.4638196572792209	ITPR3;CACNA1F
Parkinsons Disease Pathway WP2371	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	MAPK12
Sleep regulation WP3591	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	SLC29A1
Striated Muscle Contraction Pathway WP383	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ACTN4
MicroRNAs in cardiomyocyte hypertrophy WP1544	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	DVL1;GATA4
Viral Acute Myocarditis WP4298	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	ENDOG;BAX
Ebola Virus Pathway on Host WP4217	3/129	0.62930752214775	1.0	0	0	0.9302325581395349	0.43082347471841215	CLTB;ACTN4;GAS6
Ferroptosis WP4313	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	GPX4
Glycogen Synthesis and Degradation WP500	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	PPP2R3B
Microglia Pathogen Phagocytosis Pathway WP3937	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	CYBA
Retinoblastoma Gene in Cancer WP2446	2/87	0.6435930169797581	1.0	0	0	0.9195402298850575	0.40523100125149	CDT1;E2F1
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	NDUFA13
Common Pathways Underlying Drug Addiction WP2636	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	DRD4
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	TRAF2
Androgen receptor signaling pathway WP138	2/90	0.6618632480006403	1.0	0	0	0.8888888888888888	0.3668411719125685	NCOR2;STUB1
Eukaryotic Transcription Initiation WP405	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	POLR2E
GPCRs, Other WP117	2/91	0.6677839316144591	1.0	0	0	0.8791208791208791	0.3549807590642075	GRM8;DRD4
Metapathway biotransformation Phase I and II WP702	4/183	0.674662380012837	1.0	0	0	0.8743169398907104	0.3440812161739797	CHST8;GPX4;GSTP1;COMT
Ras Signaling WP4223	4/184	0.6787950265140977	1.0	0	0	0.8695652173913043	0.33690093263352294	GNGT2;GNB2;GNB3;PAK4
Regulation of Microtubule Cytoskeleton WP2038	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	DVL1
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	PAK4
NO/cGMP/PKG mediated Neuroprotection WP4008	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	CAMK2B
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	EIF4EBP1
Exercise-induced Circadian Regulation WP410	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	GSTP1
Vitamin B12 Metabolism WP1533	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	SHMT2
Neural Crest Differentiation WP2064	2/101	0.7224620897819041	1.0	0	0	0.792079207920792	0.2574972920889452	TLX2;DVL1
Integrated Breast Cancer Pathway WP1984	3/151	0.7317997732945651	1.0	0	0	0.7947019867549668	0.2481443731300127	STK11;E2F1;BAX
Genes related to primary cilium development (based on CRISPR) WP4536	2/103	0.7324409619068384	1.0	0	0	0.7766990291262135	0.24184274906292497	TEDC1;WDR34
Phosphodiesterases in neuronal function WP4222	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	PDE6C
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	TRAF2
Epithelial to mesenchymal transition in colorectal cancer WP4239	3/159	0.7630720538840987	1.0	0	0	0.7547169811320754	0.20407759787454713	JAG2;PKD1;MAPK12
Complement and Coagulation Cascades WP558	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	F12
Kit receptor signaling pathway WP304	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	MATK
MET in type 1 papillary renal cell carcinoma WP4205	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	PAK4
TYROBP Causal Network WP3945	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	GPX1
Genotoxicity pathway WP4286	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	AEN
Endochondral Ossification WP474	1/64	0.8026791537609369	1.0	0	0	0.625	0.13737512770713134	NKX3-2
Hippo-Merlin Signaling Dysregulation WP4541	2/120	0.8055060782966527	1.0	0	0	0.6666666666666666	0.1441896869343059	CDH24;PAK4
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	1/69	0.8262150460248844	1.0	0	0	0.5797101449275363	0.11066677859030163	RBP4
mRNA Processing WP411	2/126	0.8267250316625534	1.0	0	0	0.6349206349206349	0.12081468454976227	SF3A2;CPSF1
Prolactin Signaling Pathway WP2037	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	EIF4EBP1
Regulation of toll-like receptor signaling pathway WP1449	2/139	0.865708767874858	1.0	0	0	0.5755395683453237	0.08299667495615301	MLST8;MAPK12
DNA IR-damage and cellular response via ATR WP4016	1/80	0.868595756144096	1.0	0	0	0.5	0.07043872237547145	E2F1
Endoderm Differentiation WP2853	2/141	0.8709387333892648	1.0	0	0	0.5673758865248226	0.07840206816686517	MAD2L2;GATA4
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	2/144	0.8784334645253504	1.0	0	0	0.5555555555555555	0.07200839545294983	EIF4EBP1;EEF2
Allograft Rejection WP2328	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	COL5A1
Cytoplasmic Ribosomal Proteins WP477	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	RPS15
B Cell Receptor Signaling Pathway WP23	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	PIP5K1C
Pathways Regulating Hippo Signaling WP4540	1/98	0.9168609421701835	1.0	0	0	0.4081632653061224	0.03542835205394167	CDH24
Toll-like Receptor Signaling Pathway WP75	1/103	0.9267934783334831	1.0	0	0	0.38834951456310673	0.029524086681869306	MAPK12
GPCRs, Class A Rhodopsin-like WP455	3/257	0.9572910379710701	1.0	0	0	0.4669260700389105	0.020380304521611128	HTR6;CHRM4;DRD4
TGF-beta Signaling Pathway WP366	1/132	0.9650218289340243	1.0	0	0	0.30303030303030304	0.010789259770295241	BCAR1
NRF2 pathway WP2884	1/146	0.9755213863084584	1.0	0	0	0.273972602739726	0.006789916637460286	GSTP1
Nuclear Receptors Meta-Pathway WP2882	3/319	0.9872776552319148	1.0	0	0	0.3761755485893417	0.004816539241817711	GSTP1;AIP;BAX
Ciliary landscape WP4352	1/216	0.9959051074828859	1.0	0	0	0.18518518518518517	7.59870286651486E-4	WDR34
